TREAT-NMD Advisory committee for Therapeutics Symposium

31 October 2024

Developing Therapies in Rare Neuromuscular Disease

A symposium by the Advisory Committee for Therapeutics

15th anniversary of the TREAT-NMD Advisory Committee for Therapeutics (TACT)

Their first symposium by the Advisory Committee for Therapeutics will be a day filled with insightful talks, reflecting on the wealth of knowledge gleaned over the past 15 years of TACT’s operation.

 

The symposium is designed for industry professionals involved in developing treatments for rare neuromuscular diseases and offers a unique opportunity to learn from past mistakes, engage with leading experts, and gain valuable insights into the challenges and opportunities within the field. Attendees can expect interactive sessions and opportunities to pose questions to the speakers, fostering meaningful dialogue and knowledge exchange.

 

Tickets are now available! Don’t miss this unparalleled opportunity to celebrate 15 years of TACT and chart the course for future advancements in rare neuromuscular disease therapeutics.

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern